title: Age and α-synuclein expression interact to reveal a dependence of dopaminergic axons on endogenous Akt/PKB signaling.
abstract: The mechanisms underlying the chronic neurodegeneration that occurs in Parkinson's disease (PD) are unknown. One emerging hypothesis is that neural systems deteriorate and eventually degenerate due to a primary failure of either extrinsic neurotrophic support or the intrinsic cellular pathways that mediate such support. One of the cellular pathways that have been often identified in mediating neurotrophic effects is that of PI3K/Akt signaling. In addition, recent observations have suggested a primary failure of PI3K/Akt signaling in animal models and in PD patients. Therefore, to explore the possible role of endogenous Akt signaling in maintaining the viability and functionality of substantia nigra (SN) dopamine neurons, one of the principal systems affected in PD, we have used an adeno-associated viral vector to transduce them with a dominant negative (DN) form of Akt, the pleckstrin homology (PH) domain alone (DN(PH)-Akt). In addition, we have examined the effect of DN(PH)-Akt in murine models of two risk factors for human PD: advanced age and increased expression of α-synuclein. We find that transduction of these neurons in normal adult mice has no effect on any aspect of their morphology at 4 or 7weeks. However, in both aged mice and in transgenic mice with increased expression of human α-synuclein we observe decreased phenotypic expression of the catecholamine synthetic enzyme tyrosine hydroxylase (TH) in dopaminergic axons and terminals in the striatum. In aged transgenic α-synuclein over-expressing mice this reduction was 2-fold as great. We conclude that the two principal risk factors for human PD, advanced age and increased expression of α-synuclein, reveal a dependence of dopaminergic neurons on endogenous Akt signaling for maintenance of axonal phenotype.
authors.affiliation: Department of Neurology, Columbia University, New York, USA.
authors.forename: Sang Ryong
authors.initials: SR
authors.lastname: Kim
authors.forename: Vincent
authors.initials: V
authors.lastname: Ries
authors.forename: Hsiao-Chun
authors.initials: HC
authors.lastname: Cheng
authors.forename: Tatyana
authors.initials: T
authors.lastname: Kareva
authors.forename: Tinmarla F
authors.initials: TF
authors.lastname: Oo
authors.forename: W Haung
authors.initials: WH
authors.lastname: Yu
authors.forename: Karen
authors.initials: K
authors.lastname: Duff
authors.forename: Nikolai
authors.initials: N
authors.lastname: Kholodilov
authors.forename: Robert E
authors.initials: RE
authors.lastname: Burke
mesh_terms: D000375:Aging / Q000378:metabolism / Q000502:physiology*; D000818:Animals; D001369:Axons / Q000473:pathology / Q000502:physiology*; D004195:Disease Models, Animal; D059290:Dopaminergic Neurons / Q000502:physiology*; D006801:Humans; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008822:Mice, Transgenic; D020734:Parkinsonian Disorders / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology*; D051057:Proto-Oncogene Proteins c-akt / Q000235:genetics / Q000502:physiology*; D015398:Signal Transduction / Q000502:physiology*; D051844:alpha-Synuclein / Q000096:biosynthesis / Q000235:genetics*
chemical_list: C497604:SNCA protein, human; D051844:alpha-Synuclein; C514862:Akt1 protein, mouse; D051057:Proto-Oncogene Proteins c-akt